Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
69.85 USD
-0.13%
Market Closed
Updated:
May 9, 2024
Prestige Consumer Healthcare Inc
Change in Working Capital
|
Prestige Consumer Healthcare Inc
Change in Working Capital Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Change in Working Capital
-$44.2m
|
CAGR 3-Years
-428%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-14%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Change in Working Capital
-$94m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Change in Working Capital
-$356m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-394%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Change in Working Capital
-$2.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-24%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Change in Working Capital
-$5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-33%
|
See Also
What is Prestige Consumer Healthcare Inc's Change in Working Capital?
Change in Working Capital
-44.2m
USD
-44.2m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Change in Working Capital amounts to -44.2m USD.
What is Prestige Consumer Healthcare Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-14%
-14%
Over the last year, the Change in Working Capital growth was 4%. The average annual Change in Working Capital growth rates for Prestige Consumer Healthcare Inc have been -428% over the past three years , -31% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
